C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1992
11/17/1992	US5164311 Preparation of an antibody-enzyme conjugate
11/17/1992	US5164304 Method and vectors for stabilizing hirudin and human laminin b1 expression
11/17/1992	US5164300 Fluorescence, AIDS
11/17/1992	US5164296 Cardiovascular, renal
11/17/1992	US5164180 Bacillus thuringiensis isolates active against lepidopteran pests
11/17/1992	CA2109315A1 Method of suppressing tumor formation in vivo by administering je/mlp-1
11/17/1992	CA2068811A1 Protein from lactic acid bacteria
11/17/1992	CA1310445C Derivatives of aminopimelic acid, process for their preparation and their application as medecines
11/17/1992	CA1310444C Cck8 derived peptides, their preparation, and pharmaceutical compositions containing them
11/17/1992	CA1310286C Isolation of a gene encoding human thyrotropin beta subunit
11/17/1992	CA1310266C Thymus derivative active after oral administration, methods of preparation and pharmaceutical compositions
11/17/1992	CA1310264C Modified antibodies for enhanced clearance
11/16/1992	WO1992020808A1 Genomic modifications with homologous dna targeting
11/16/1992	WO1992001002A1 Tumor necrosis factor activity inhibitor and production thereof
11/16/1992	EP0528827A4 Protein partner screening assays and uses thereof.
11/16/1992	CA2092695A1 Genomic modifications with homologous dna targeting
11/16/1992	CA2042625A1 Transgenic non-human animal carrying a non-infectious hiv genome
11/15/1992	WO1992020708A1 Peptide inhibitors of inflammation
11/15/1992	WO1992020373A1 Heteroconjugate antibodies for treatment of hiv infection
11/15/1992	CA2103139A1 Peptide inhibitors of inflammation
11/15/1992	CA2102511A1 Heteroconjugate antibodies for treatment of hiv infection
11/14/1992	WO1992020805A1 Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence
11/14/1992	CA2068478A1 Peptide compound and a process for the preparation thereof
11/12/1992	WO1992020060A1 Electrophoretic display panel with tapered grid insulators and associated methods
11/12/1992	WO1992019969A1 Immunoassay for detecting group b streptococcus
11/12/1992	WO1992019760A1 In vitro methods for determining in vivo thrombotic events
11/12/1992	WO1992019758A1 Transmission-blocking vaccine against malaria
11/12/1992	WO1992019757A1 Recombinant b oligomer of pertussis toxin
11/12/1992	WO1992019754A1 Kit for detecting a genetic predisposition for vascular aneurysms
11/12/1992	WO1992019750A1 Hybrid transposon with a pt-operon, plasmids and bacterial strains therefor
11/12/1992	WO1992019749A1 Targeted delivery of genes encoding cell surface receptors
11/12/1992	WO1992019746A1 Recombinant immunocastration vaccine and polypeptides useful for same
11/12/1992	WO1992019743A2 Hcv genomic sequences for diagnostics and therapeutics
11/12/1992	WO1992019742A1 NOVEL HYBRID, SOLUBLE AND UNCLEAVED gp160 VARIANT
11/12/1992	WO1992019741A1 Hbv virus surface proteins with reduced host carbohydrate
11/12/1992	WO1992019740A1 Multiple hepatitis b virus surface proteins which form particles
11/12/1992	WO1992019739A1 Novel nematode-active toxins and genes which code therefor
11/12/1992	WO1992019737A1 Process for producing a monocyte chemotactic factor polypeptide and a strain for the production thereof
11/12/1992	WO1992019736A1 Growth hormone antagonists
11/12/1992	WO1992019735A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND
11/12/1992	WO1992019734A1 Binding domains in notch and delta proteins
11/12/1992	WO1992019733A1 Thyroidal receptor for n-acetylglucosamine
11/12/1992	WO1992019730A1 Dna construct for in vivo expression of a human gene
11/12/1992	WO1992019727A1 Isolation of macrophage migration inhibition factor from ocular lens and dna which encodes the factor
11/12/1992	WO1992019723A1 Method of isolating ligands which bind neutrophil receptors
11/12/1992	WO1992019651A1 Luteinizing hormone releasing hormone antagonist peptides
11/12/1992	WO1992019649A1 Antigens recognized by antibodies of rhumatoid polyarthritis, and preparation and use thereof
11/12/1992	WO1992019647A1 Integrin alpha subunit cytoplasmic domain polypeptides, antibodies and methods
11/12/1992	WO1992019646A1 Analog of endothelial leukocyte adhesion molecule (elam)
11/12/1992	WO1992019645A1 A novel polypeptide with affinity to lipopolysaccharides and their uses
11/12/1992	WO1992019644A1 Vasorelaxant peptide
11/12/1992	WO1992019635A1 Antigen recognized by antibodies associated with paraneoplastic opsoclonus and methods of use thereof
11/12/1992	WO1992019269A1 Antibody recognizing endothelial cell ligand for leukocyte cr3
11/12/1992	WO1992019268A1 New hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines
11/12/1992	WO1992019266A1 Recombinant virus expressing carcinoembryonic antigen and methods of use thereof
11/12/1992	WO1992019263A1 Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
11/12/1992	WO1992019257A1 Compositons for the treatment of chronic fatigue syndrome
11/12/1992	WO1992019253A1 CCK ANALOGS CONTAINING α-SUBSTITUTED AMINO ACIDS
11/12/1992	WO1992019252A1 Antisense oligonucleotides to c-kit proto-oncogene and uses thereof
11/12/1992	WO1992019248A1 High affinity mannose receptor ligands
11/12/1992	WO1992019239A1 Treatment of aberrant cellular states with biomodulators
11/12/1992	WO1992019106A1 Novel bacillus thuringiensis isolates for controlling acarides
11/12/1992	WO1992003564A1 Plant fatty acid synthases
11/12/1992	CA2109527A1 Amino-acid sequence homologies between selectins and b pertussis toxin-peptides derived therefrom, antibodies thereto and pharmaceutical compositions
11/12/1992	CA2109332A1 Antibody recognizing endothelial cell ligand for leukocyte cr3
11/12/1992	CA2109090A1 Immunoassay for detecting group b streptococcus
11/12/1992	CA2108248A1 Novel bacillus thuringiensis isolates for controlling acarides
11/12/1992	CA2108029A1 Glycam-1(sgp 50), a selectin ligand
11/12/1992	CA2107915A1 Antisense oligonucleotides to c-kit proto-oncogene and uses thereof
11/12/1992	CA2106765A1 Cck analogs containing ó-substituted amino acids
11/12/1992	CA2102508A1 Electrophoretic display panel with tapered grid insulators and associated methods
11/12/1992	CA2084876A1 Antigens specifically recognized by specific antibodies of rheumatoid arthritis, their constituent proteins, preparation and applications
11/11/1992	WO1992020714A1 Control of milk secretion
11/11/1992	WO1992020358A1 Novel biologically active peptide compositions and uses therefor
11/11/1992	EP0512750A1 Yeast derived mitogen
11/11/1992	EP0512733A2 Modified complement system regulator
11/11/1992	EP0512260A2 Stable pura vectors and uses thereof
11/11/1992	EP0512102A1 Proteins purified from mammalian gestational tissue which control cell proliferation
11/11/1992	EP0512087A1 Process for reactivating denatured protein.
11/11/1992	EP0512074A1 Molecules with antibody combining sites that catalyse hydrolysis reactions
11/11/1992	EP0512042A1 Glp-1 analogs useful for diabetes treatment
11/11/1992	EP0512023A1 Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens
11/11/1992	EP0511978A1 Method of purifying recombinant polypeptides.
11/11/1992	EP0511970A1 Method for preparing an enzymatic hydrolyzate.
11/11/1992	EP0511964A1 METHOD FOR PREPARING A PROTEIN COMPRISING AT LEAST ONE INTRAMOLECULAR DISULPHIDE BOND BY OXIDATION, AT A pH OF LESS THAN 5.0, OF THE REDUCED RECOMBINANT PROTEIN.
11/11/1992	EP0511959A1 Method for recovering solubilized proteins
11/11/1992	EP0202300B1 Cdna clones coding for polypeptides exhibiting human granulocyte macrophage and eosinophil cellular growth factor activity
11/11/1992	CA2102800A1 Control of milk secretion
11/11/1992	CA2086111A1 Biologically active peptide compositions and uses therefor
11/10/1992	WO1992019279A1 Phospholipid-targeted thrombolytic agents
11/10/1992	US5162601 Plant potyvirus expression vector with a gene for protease
11/10/1992	US5162515 Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus
11/10/1992	US5162507 Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
11/10/1992	US5162503 Purification of interleukin-2 by receptor-affinity chromatography
11/10/1992	US5162502 Modified trichokirin and their preparation for use in conjugates as inhibitors of protein synthesis
11/10/1992	US5162499 Synthetic peptides for the treatment of AIDS
11/10/1992	US5162498 Synthetic yeast leader peptides
11/10/1992	US5162497 Bradykinin analogs with non-peptide bond
11/10/1992	US5162430 To a synthetic hydrophilic polymer, polyoxyethylene glycol; wound healing, slow release drug delivery
11/10/1992	US5162306 Follicle Stimulating Hormone, Luteinizing Hormone

1 ... 2712 2713 2714 2715 2716 2717 2718 2719 2720 2721 2722 2723 2724 2725 2726 2727 2728 2729 2730 2731 2732 ... 2916